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Abstract
Background: The present study aimed at examining whether methodological strategies from a previously
implemented study design could be transferred to the evaluation of the psychological and physiological effects of
a music therapy intervention working with vibroacoustic stimulation in palliative care.
Method: Nine participants suffering from advanced cancer took part in single-sessions of music therapy, lasting for
30 min. The live music therapy intervention utilized singing chair sounds and vocal improvisation. Visual analogue
scales (VAS) were used to assess self-ratings of pain, relaxation, and well-being before and after each session. During
the intervention, we continuously recorded heart rate variability (HRV) as a measure of autonomic functioning. Data
collection was complemented by a semi-structured interview to explore subjective experiences in more detail.
Feasibility was defined as the ability to complete 80 % of the sessions in accordance with the study protocol.
Results: In 5 out of 9 sessions (55 %) it was possible to deliver the intervention and obtain all data as intended.
VAS assessment was feasible, although graphical and statistical examination revealed only marginal mean changes
between pre and post. HRV recordings were subject to artifacts. While HRV parameters differed between individuals,
mean changes over time remained relatively constant. Interview data confirmed that the individual perception was
very heterogeneous, ranging from “calming” to “overwhelming”.
Conclusion: The criterion of feasibility was not met in this study. Physiological data showed high attrition rates,
most likely due to movement artifacts and reduced peripheral blood flow in some participants’ extremities.
Examination of individual-level trajectories revealed that vibroacoustic stimulation may have an impact on the
autonomic response. However, the direction and mechanisms of effects needs to be further explored in future
studies.
Trial registration: German Clinical Trials Register – DRKS00006137 (July 4th, 2014).
Keywords: Music therapy, Palliative care, Feasibility, Singing chair, End-of-life care, Advanced cancer patients, Heart
rate variability
Background
Music therapy is defined as the “[…] systematic process
of intervention wherein the therapist helps the client to
promote health, using music experiences and the rela-
tionships that develop through them as dynamic forces
of change” [1] and thereby contrasts ‘music medicine’ or
mere ‘music listening’ interventions that do not require
the presence of a professional therapist. During the last
decades, music interventions have increasingly been im-
plemented as complementary treatments in different
medical settings, such as oncology, intensive or palliative
care [2–4]. The World Health Organisation defines pal-
liative care as “[…] an approach that improves the qual-
ity of life of patients and their families facing the
problems associated with life-threatening illness” [5].
Palliative care holds a holistic and multidisciplinary
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perspective on the patients’ and family caregivers’ needs.
Hence, alternative and complementary treatments such
as music therapy have been integrated into palliative
care since the foundation of the first institutions in the
late 1970’s [6].
Today, the work of music therapists receives high ac-
ceptance by other health-care professionals in end-of-life
care [7], and music therapy interventions are among the
most frequently used complementary treatments in US
hospices [8, 9]. The aim of music therapy in this field is
to improve or maintain the patient’s quality of life by
supporting physical symptom management (e.g. pain,
stress symptoms, shortness of breath), addressing emo-
tional needs, enhancing communication, and facilitating
spiritual experiences [10]. Families and caregivers may
participate in the therapeutic process, and music therapy
programs can address the needs of bereaved family
members during feelings of loss and grief [11, 12]. The
most common interventions encompass the use of im-
provisation and songs, as well as receptive relaxation
and imagery techniques [10]. In contrast to active music
therapy - where the patient himself plays an instrument
or uses his voice – receptive techniques require very lit-
tle or no physical activity and mental strain, and thus,
are frequently used in end-of-life care settings.
Among relaxation and imagery techniques, the appli-
cation of monotone instruments and vibroacoustic
stimulation has increasingly gained importance during
the past years [13]. One possible rationale for the use of
vibroacoustic stimulation in medical settings is the idea
that musical and emotional experiences may be intensi-
fied if a person not only listens to music, but actually
senses the tactile vibration. Therapeutic instruments
making use of this phenomenon are the monochord
[14], body tambura [13], and the singing chair [15].
Despite its long tradition and high acceptance in pal-
liative care, empirical research on the effects of music
therapy is still rare. A recent review concluded that the
available evidence is not sufficient to give a valid recom-
mendation in favor or against the use of music therapy
in this field [16]. The 2010 Cochrane review (withdrawn
from the database in 2014) included five controlled clin-
ical trials that showed small to moderate effects of music
therapy interventions on quality of life, pain, as well as
emotional and spiritual well-being [4, 17–21]. Further
pilot studies showed first evidence that music therapy
may be effective in facilitating communication [22] and
reducing cortisol stress level [23]. However, the risk of
bias in most studies was high, due to small sample sizes,
a lack of control conditions, unclear randomization and
concealment methods, or insufficient statistical reporting
[4, 24]. A recently conducted randomized controlled trial
(RCT) implemented a more rigorous research design
and showed that music therapy reduced subjective rat-
ings of pain intensity among 200 hospitalized patients
with advanced cancer. Another RCT is currently being
accomplished by our own research group [25].
Feasibility studies form an important step towards the
implementation of larger-scale experimental research, as
they offer the opportunity to evaluate which outcome
measures are most suitable to quantify the effect, and to
identify inadequate methodological ideas. Particularly, in
challenging and sensitive research settings such as end-
of-life care, they may help to prevent researchers from
implementing clinical trials that might not be feasible or
capable of producing valid results [26].
One goal of the previous RCT [25] was to explore pos-
sibilities for follow-up studies. Therefore, the aim of the
present pilot study was to investigate, whether it was
feasible to transfer elements of the previous research de-
sign to the evaluation of the effects of vibroacoustic
stimulation for advanced cancer patients in palliative
care.
Methods
Participants and procedures
The study received ethical approval by the Ethics Com-
mittee of the Medical Faculty at Heidelberg University
(S - 406/2012). All participants were contacted and re-
cruited at the palliative care unit of St. Vincencius Hos-
pital in Heidelberg, Germany. The inclusion and
exclusion criteria listed in Table 1 were assessed to de-
termine eligibility for study participation.
The present study utilized a single-group pre-post
mixed-methods design with continuous recordings of
physiological data. Participants eligible for study inclu-
sion were contacted in their rooms, were informed
about the study objectives, and asked to sign the
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Receiving palliative care Terminal phase
Sufficient understanding of German or English language Cognitive impairments (e.g. brain metastases, ICD 10: C71, C72)
Apallic syndrome (ICD 10: G93.80)
Deafness (ICD 10: H90, H91)
Restlessness and agitation (ICD 10: R45.1)
Immobility (unable to sit in an upright position for 30 min)
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informed consent sheet. If a patient expressed willing-
ness to participate, the investigator left the room and
shortly after returned together with the music therapist,
the singing chair, and the measuring devices. After base-
line assessment of relaxation, well-being, and pain via
visual analogue scales (VAS) and a five-minute baseline
recording of heart rate variability (HRV), the investigator
left the room and the music therapist initiated the inter-
vention. Twenty minutes later, the investigator returned
for post-test assessment of VAS and HRV, followed by a
semi-structured qualitative interview on subjective expe-
riences during the intervention. The entire session dur-
ation was approximately 30–35 min.
Intervention
A singing chair was used for live musical play in the
music therapy relaxation intervention. A singing chair is
a musical instrument designed for therapeutic purposes
by instrument maker Bernhard Deutz1. At the backside
of the instrument, 69 steel strings are vertically placed in
tuning of the traditional Indian tambura (i.e. strings were
tuned sequentially in the notes A-d-d-D). A recent pilot
study found that after five minutes of a singing chair
intervention, apparently healthy students showed a re-
duction in heart rate and anxiety [15]. In a qualitative
interview study, terminally-ill patients reported to feel
more relaxed and calm, and to have experienced pleas-
ant body sensations and visualizations after a music
therapy session using the body tambura (an instrument
with similar characteristics) [13].
The intervention was carried out by a music therapist
with several years of experience in working with
terminally-ill patients. The musical intervention started
with a short body scan (i.e. a mindfulness exercise focus-
ing attention on different body parts) accompanied by
slow and gentle play of the backside strings, lasting for
approximately 3 min. The therapist then initiated a vocal
improvisation in an ionian or mixolydian mode (i.e. dia-
tonic musical keys defined by a sequence of whole steps
and half steps), while she gradually increased the vol-
ume, dynamics, and range of her musical play. During
this improvisation, the music therapist tried to
synchronize and modify musical and breathing meter.
After 10–12 min, the intensity of music and singing
were slowly reduced and finally faded out. The therapist
gently asked the participant to return his attention to
the present moment. Afterwards the patient had the op-
portunity to reflect on his subjective experiences during
the singing chair music.
Outcomes
Three VAS ranging from 0 to 10 were used to assess pre
and post measures of patients’ subjective experience of
pain, relaxation, and well-being. The scales’ endpoints
were illustrated with good vs. bad smileys and contained
a colour code from red to green.
As a peripheral measure of autonomic function, we
continuously recorded the intervals between successive
heart beats in milliseconds (i.e. HRV). High frequent
(HF) oscillation in these inter-beat-intervals (IBI) is indi-
cative of parasympathetic activity, and is controlled pre-
dominantly via the vagus nerve [27]. Thus, a relaxation
response [28] was expected to manifest in a decrease in
absolute heart rate (mean HR) and in an increase of high
frequent variation in heart rate over time (HF power).
We used a NeXus-16 Bluetooth interface together with a
photoplethysmography finger sensor for non-invasive
measurement of HRV. The signal was recorded by Bio-
Trace+ software on a laptop computer inside the pa-
tient’s room. IBI tables for the entire session duration
were exported for each participant. Kubios v2.1 was used
to extract six successive time segments of 5 min dur-
ation for further analyses with IBM SPSS Statistics 20
for each session.
Since no evidence exists on the effects (and possible
side effects) of the use of singing chair interventions in
end-of-life care, we added a semi-structured interview
with an open answer format to explore the assumed
mechanisms of the intervention in more detail. The
questions focused on spontaneous reactions, physical
sensations, cognitive perceptions, and subjective feelings
after the intervention, as well as on the comparison of
the perceived effects to similar relaxation exercises.
Analysis
Answers to open-ended interview questions were inter-
preted according to content analysis [29]. Statistical ana-
lysis of HRV and VAS data was performed by using IBM
SPSS Statistics 20. Since we expected a small sample size
in this pilot study, the analysis focused on descriptive
statistics (means and standard deviations) and confi-
dence intervals (CI). For reason of completeness, p-
values from repeated-measures analysis of variance
(RM-ANOVA) were calculated. Feasibility was defined
as the ability to complete 80 % of the single sessions in
accordance with the study protocol. We attempted to re-
cruit 10 participants for this study.
Results
Within the available amount of time (March to July
2014), it was possible to include a total of 9 participants
(6 female) with a mean age of 59.9 (±7.15) years in this
study. All participants suffered from progressive, life-
threatening cancer: liver carcinoma (n = 3), metastatic
melanoma (n = 1), prostatic carcinoma (n = 1), leukemia
(n = 1), angiosarcoma (n = 1), gastric cancer (n = 1), and
pancreatic cancer (n = 1). The average Karnofsky index
(i.e. a rating system on functional impairment) was rated
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M = 45.0 %, SD = ±10.7 % (mean ± standard deviation),
indicating that the participants on average were in need
of special care and assistance. The most frequently re-
ported symptoms among all participants were immobil-
ity, pain, fatigue and loss of appetite, as rated by the
physician in charge. Figure 1 depicts a flow diagram and
shows that in 5 out of 9 participants (56 %) the interven-
tion and study protocol could be delivered as intended.
VAS data collection was completed in 8 of 9 partici-
pants. One participant showed signs of severe exhaus-
tion immediately after the intervention and was not able
to respond to post-test questions. Figure 2 shows mean
values and 95 % confidence intervals (CI) for pre and
post VAS scores. For all three variables, patients showed
very little change over time. Marginal improvements
were observed for pain (mean difference, MD = -0.54)
and well-being (MD = 0.69), and a minimal decline oc-
curred for relaxation (MD = -0.33). However, CIs were
highly overlapping and RM-ANOVA did not detect any
statistically significant differences (all p > .05; see
Table 2).
For only 5 of the 9 sessions, a complete 30-min HRV
data set was recorded and could be used for further ana-
lysis. Two sessions had to be excluded due to movement
artifacts, and in another two cases the recordings were
biased, most likely because of severely reduced
peripheral blood flow. Because of the very small data-
base, Figs. 3a and 3b contain patients’ individual trajec-
tories in addition to the mean variation over time (solid
line). Graphical examination did not reveal relevant
changes in mean HR. Only one participant (P01) showed
the expected decrease in HR when the actual interven-
tion started (time segment 2). Regarding vagally-
mediated HRV (HF power), baseline values and time
courses differed extensively between participants. While
P10 showed the expected quadratic trajectory (increase
during the intervention, decrease to baseline afterwards),
the HF component of P1 strongly declined. All other
participants’ values did not change considerably over
time. As Table 3 indicates, none of the tested quadratic
trends (as well as linear and cubic trends) was statisti-
cally significant (all p > .05).
It was possible to complete six semi-structured inter-
views, as three participants experienced symptoms of fa-
tigue or tiredness after the intervention, and were not
able to answer all of the questions. Spontaneous reac-
tions of respondents to the experienced singing chair
intervention were heterogeneous and ranged from
“slightly sceptic” to “overwhelming” and “enthusiastic”.
Two of the research subjects perceived physical changes
and reported improvement in breathing and relaxation
of the muscles. Regarding cognitive changes, three
Fig. 1 Patient flow chart
Warth et al. BMC Complementary and Alternative Medicine  (2015) 15:436 Page 4 of 8
patients reported that they felt sleepier than before the
onset of the intervention. One respondent reported an
emergence of negative visualisation without feeling of a
strong emotional arousal. Four respondents felt calmer
and more relaxed, although one patient reported to be
more aroused afterwards. Compared to previous experi-
ence with relaxation methods, one participant rated the
singing chair intervention as less effective, two partici-
pants were not able to find any qualitative differences
and three participants had not attended any relaxation
exercises before.
Discussion
The primary aim of this feasibility study was to examine
whether the procedures and outcomes from a recently
implemented study [25] could be transferred to the
evaluation of a newly developed singing chair interven-
tion in palliative care. Feasibility was defined as the abil-
ity to complete 80 % of the interventional sessions in
accordance with the study protocol. This criterion was
not met, as only 5 out of 9 participants (56 %) completed
all data including psychological and physiological mea-
sures. Recruitment of participants was difficult and
time-consuming. Many patients were not eligible for
study participation due to the exclusion criteria (Table 1).
Particularly, the requirement to sit in an upright position
for up to half an hour led to a reduction in the number
of eligible subjects.
VAS were used to measure participants’ subjective
feeling of pain, well-being and relaxation before and
after the intervention. Graphical and statistical analysis
showed no relevant mean differences between pre- and
post-values in any of the three outcomes. The largest
improvement occurred for well-being with a mean dif-
ference of MD = 0.69 (±2.41). This contradicts findings
from our previous study using a monochord interven-
tion at bedside, where we found mean changes from pre
to post of up to two points on a VAS with a larger sam-
ple size of N = 84 [30]. However, it would be false to
conclude that the singing chair intervention does not
affect these three dimensions, in general. Examination of
the individual values revealed rather favorable baseline
scores for pain (M = 1.65, SD = 2.21), relaxation (M =
7.90, SD = 1.64), and well-being (M = 7.05, SD = 1.77),
giving a possible explanation for the lack of observable
improvements. While the majority of terminally-ill pa-
tients in palliative care suffer considerably from symp-
toms such as pain, stress, and anxiety [31], the relatively
strict inclusion criteria in the present study obviously led
Fig. 2 Pre to post comparison of VAS (N = 8). Means and 95 % confidence intervals
Table 2 Changes in mean (±SD) VAS scores from pre- to
post-intervention (N = 8)
Pre Post MD CI of MD p*
Pain 1.65 (2.21) 1.11 (1.58) −0.54 (1.17) [-0.44, 1.51] .23
Relaxation 7.90 (1.64) 7.56 (2.41) −0.33 (2.05) [-1.37, 2.05] .66
Well-being 7.05 (1.77) 7.74 (1.66) 0.69 (2.41) [-2.70; 1.32] .45
MD =mean difference, CI = 95 % confidence interval
*p-values from RM-ANOVA (considered significant, if p < .05)
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to a highly selective, non-representative sample. Regard-
ing feasibility, however, the VAS proved to be manage-
able and economic measures of current subjective states.
For VAS on acute pain, previous studies found evidence
for adequate reliability and validity [32, 33].
Only minor changes were observed in the graphical
analysis of mean HRV parameters. However, important
inferences can be drawn from the individual trajectories
displayed in Figs. 3a and 3b: The variability between in-
dividual intercepts and slopes seemed to have a higher
impact than the mean changes over time, resulting in
the mean curve not adequately representing the majority
of individual trajectories. This issue appears to apply to
many statistical analyses on physiological data as a study
outcome, and has been addressed recently in a methodo-
logical paper, suggesting the integration of more ideo-
graphic approaches to data analysis in such cases [34].
Growth curve models (or multilevel analyses) seem to
be suitable as they allow for characterizing both group-
level and individual-level effects, accounting for inter-
individual differences in regression intercepts and slopes.
The relatively high percentage of HRV measuring arti-
facts in the present study of 44 % is not representative of
our research experience in palliative care in general,
where we had attrition rates between 10 % and 20 % for
30-min of HRV recording. However, the need to sit in
an upright position might have contributed to move-
ment artifacts and erroneous recordings. We would,
however, still reject the alternative to use multi-point
electrocardiogram (ECG) recordings, as electrode place-
ment may require too much strain for some patients in
palliative care.
Analysis of the semi-structured interviews is accordant
with findings from the examination of individual HRV
scores, illustrating that – in contrast to a monochord
intervention – the direction of effects in a singing chair
intervention cannot yet be predicted in a general man-
ner. Although most patients perceived the sounds and
tactile stimulation as positive and calming, some patients
reported experiences of arousal or being overwhelmed.
The present investigation was designed as a pilot feasi-
bility study, and hence, faced several methodological
limitations. Firstly, we did not implement randomization
or a control condition. The reason was that our previous
study successfully utilized a pre-recorded mindfulness
exercise as an active and ethically sound control inter-
vention. If a larger-scale RCT was to be designed on the
basis of findings from the present pilot study, this mind-
fulness exercise may be used as a control condition. Sec-
ondly, we included a small and non-representative
sample, impeding the possibility to draw causal infer-
ences on the effectiveness of vibroacoustic stimulation
from the presented statistical tests. Finally and as dis-
cussed above, the inclusion and exclusion criteria used
Fig. 3 Individual and mean changes of HRV parameters over time
(N = 5). a Heart Rate, (b) HF Power
Table 3 Changes in mean (±SD) HR and HF over time (N = 5)
Pre Intervention Post
T1 T2 T3 T4 T5 T6 p*
HR 97.19 94.75 94.60 96.06 96.28 95.98 .50
(15.09) (18.16) (16.76) (15.64) (15.17) (12.34)
HF 210.74 165.59 117.77 148.27 137.53 94.60 .81
(273.19) (164.91) (148.24) (224.55) (124.16) (87.43)
T = 5-min time segment, HR = heart rate [bpm], HF = power in the high
frequency spectrum [ms2]; *p-values for quadratic trends over time in
RM-ANOVA (considered significant, if p < .05)
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in this pilot study showed to be problematic in ways that
they significantly limited the number of eligible patients
and that they were in part imprecisely defined. We
would therefore recommend the use objective indicators
for criteria such as “cognitive impairment” or “final
phase” in future studies (e.g. use of the Karnofsky scale).
Conclusion
Music therapy is a frequently used complementary thera-
peutic approach in end-of-life care. In response to the
attested lack of high-quality research in this field [4, 16],
attempts have been initiated to create an evidence-based
rationale in recent years [25, 35]. The present study ex-
plored whether methodological strategies from a previ-
ously implemented research design could be transferred
to the evaluation of a singing chair intervention for hospi-
talized patients in a palliative care unit. Results suggest
that the chosen design integrating both psychological and
physiological outcomes in the context of a strictly stan-
dardized protocol was not feasible for the population and
intervention under investigation. This, however, does not
imply that interventions using vibroacoustic stimulation
are not effective in improving patients’ quality of life or
subjective well-being. Instead we recommend exploring
adequate endpoints and possible working mechanisms in
future qualitative and mixed-methods studies prior to the
implementation of larger-scale effectiveness research.
Endnotes
1http://www.deutz-klangwerkstatt.de/instrumente/
klangstuhl
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